Relationship between tumour endothelial cell apoptosis and tumour blood flow shutdown following treatment with the antivascular agent DMXAA in mice.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis; D003110:Colonic Neoplasms / Q000098:blood supply* / Q000473:pathology* / Q000662:veterinary; D042783:Endothelial Cells / Q000502:physiology; D020287:In Situ Nick-End Labeling; D051379:Mice; D018345:Mice, Knockout; D009374:Neoplasms, Experimental; D012039:Regional Blood Flow; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis / Q000494:pharmacology; D044004:Xanthones / Q000494:pharmacology*
D000970:Antineoplastic Agents; D014409:Tumor Necrosis Factor-alpha; D044004:Xanthones; C066668:vadimezan